Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

The US Food and Drug Administration (FDA) is featuring an upcoming town hall, set to begin Tuesday at 1 pm in Washington.

Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work ...

Surgeons in southern California successfully completed the world's first-ever human bladder transplant on 41-year-old Oscar ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.

The FDA has approved Novavax’s COVID-19 vaccine, Nuvavoxid, for use in adults 65 and older and in individuals ages 12-64 who have at least one underlying health condition. The approval is based on ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.